Zobrazeno 1 - 10
of 18
pro vyhledávání: '"365"'
Autor:
Hiroyuki Ito, Keita Nakane, Noriyasu Hagiwara, Makoto Kawase, Daiki Kato, Koji Iinuma, Kenichiro Ishida, Torai Enomoto, Minori Nezasa, Yuki Tobisawa, Takayasu Ito, Takuya Koie
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2758-2768 (2024)
We aimed to investigate the differences in renal function between patients who underwent single inner-layer renorrhaphy (SILR) or double-layer renorrhaphy (DLR) among those with renal tumors who underwent robot-assisted partial nephrectomy (RAPN). Th
Externí odkaz:
https://doaj.org/article/cad6b918b3cb44309925be131a070d63
Autor:
Pradeep Kumar Gupta, Stepan Orlovskiy, Fernando Arias-Mendoza, David S. Nelson, Aria Osborne, Stephen Pickup, Jerry D. Glickson, Kavindra Nath
Publikováno v:
Cancers, Vol 16, Iss 2, p 365 (2024)
Dabrafenib therapy for metastatic melanoma focuses on blocking growth-promoting signals produced by a hyperactive BRAF protein. We report the metabolic differences of four human melanoma cell lines with diverse responses to dabrafenib therapy (30 mg/
Externí odkaz:
https://doaj.org/article/bd053a736bc146e48e781f2d1ddfa4a8
Publikováno v:
Cancers, Vol 15, Iss 15, p 3936 (2023)
Diagnosing cancer may be expedited by decreasing referral risk threshold. Clinical Practice Research Datalink participants (≥40 years) had a positive predictive value (PPV) ≥3% feature for breast, lung, colorectal, oesophagogastric, pancreatic, r
Externí odkaz:
https://doaj.org/article/9c30c68bee184f3bacead1abd91a0095
Publikováno v:
Current Oncology, Vol 29, Iss 4, Pp 2798-2807 (2022)
The BC-brain questionnaire was developed by BC Cancer to detect health problems in patients with central nervous system (CNS) tumours in routine clinical care, treated with radiotherapy (RT), as part of the Prospective Outcomes and Support Initiative
Externí odkaz:
https://doaj.org/article/b5139a0e7d3842ad8c481caa5fcb84aa
Autor:
Roberta Maltoni, William Balzi, Tania Rossi, Francesco Fabbri, Sara Bravaccini, Maria Teresa Montella, Ilaria Massa, Lucia Bertoni, Fabio Falcini, Mattia Altini
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 433-438 (2022)
The risk of relapse for early breast cancer (BC) patients persists even after decades and to date, no specific and sensitive effective circulating biomarker for recurrence prediction has been identified yet. The international guidelines do not recomm
Externí odkaz:
https://doaj.org/article/bfdd26a08f7c46bbbf80dabff4687db6
Autor:
Luca Nicosia, Filippo Pesapane, Anna Carla Bozzini, Antuono Latronico, Anna Rotili, Federica Ferrari, Giulia Signorelli, Sara Raimondi, Silvano Vignati, Aurora Gaeta, Federica Bellerba, Daniela Origgi, Paolo De Marco, Giuseppe Castiglione Minischetti, Claudia Sangalli, Marta Montesano, Simone Palma, Enrico Cassano
Publikováno v:
Cancers, Vol 15, Iss 3, p 964 (2023)
The study aimed to evaluate the performance of radiomics features and one ultrasound CAD (computer-aided diagnosis) in the prediction of the malignancy of a breast lesion detected with ultrasound and to develop a nomogram incorporating radiomic score
Externí odkaz:
https://doaj.org/article/60f5fac223f7452babc393ed019136ce
Publikováno v:
Cancers, Vol 15, Iss 2, p 365 (2023)
Hepatocellular carcinoma (HCC) is the sixth most common malignant tumour and the third leading cause of cancer death in the world. The emerging field of radiomics involves extracting many clinical image features that cannot be recognized by the human
Externí odkaz:
https://doaj.org/article/9b8103090e164073ab20a636aefd94ea
Autor:
Antonella Turchiano, Daria Carmela Loconte, Rosalba De Nola, Francesca Arezzo, Giulia Chiarello, Antonino Pantaleo, Matteo Iacoviello, Rosanna Bagnulo, Annunziata De Luisi, Sonia Perrelli, Stefania Martino, Carlotta Ranieri, Antonella Garganese, Alessandro Stella, Cinzia Forleo, Vera Loizzi, Marco Marinaccio, Ettore Cicinelli, Gennaro Cormio, Nicoletta Resta
Publikováno v:
Cancers, Vol 14, Iss 2, p 365 (2022)
Background: Pathogenic variants in homologous recombination repair (HRR) genes other than BRCA1/2 have been associated with a high risk of ovarian cancer (OC). In current clinical practice, genetic testing is generally limited to BRCA1/2. Herein, we
Externí odkaz:
https://doaj.org/article/b86edfeb9f6344f797a86c7b64d73e99
Publikováno v:
Cancers, Vol 13, Iss 22, p 5787 (2021)
Gastrointestinal stromal tumors (GIST) are common mesenchymal tumors, and their effective treatment depends upon the mutational subtype of the KIT/PDGFRA genes. We established deep convolutional neural network (DCNN) models to rapidly predict drug-se
Externí odkaz:
https://doaj.org/article/114e70598c6a4b06a1bc72873254d566
Autor:
Maria Barca-Hernando, Andres J. Muñoz-Martin, Eduardo Rios-Herranz, Ignacio Garcia-Escobar, Carmen Beato, Carme Font, Estefania Oncala-Sibajas, Alfonso Revuelta-Rodriguez, Maria Carmen Areses, Victor Rivas-Jimenez, Aitor Ballaz-Quincoces, Maria Angeles Moreno-Santos, Juan-Bosco Lopez-Saez, Iria Gallego-Gallego, Teresa Elias-Hernandez, Maria Isabel Asensio-Cruz, Leyre Chasco-Eguilaz, Gonzalo Garcia-Gonzalez, Purificacion Estevez-Garcia, Lucia Marin-Barrera, Remedios Otero-Candelera, Sergio Lopez-Ruz, Jorge Lima-Alvarez, Jose Maria Sanchez-Diaz, Macarena Real-Dominguez, Maria Carmen Borrego-Delgado, Samira Marin-Romero, Luis Jara-Palomares
Publikováno v:
Cancers, Vol 13, Iss 11, p 2517 (2021)
Anemia is a common condition in cancer patients and is associated with a wide variety of symptoms that impair quality of life (QoL). However, exactly how anemia affects QoL in cancer patients is unclear because of the inconsistencies in its definitio
Externí odkaz:
https://doaj.org/article/ed82c29ac0524520896190c954491a0d